(Q42805654)

7 November 2017

title

Diminished production of nitric oxide synthase cofactor tetrahydrobiopterin by rosiglitazone in adipocytes (English)

1 reference

7 November 2017

1 reference

1 reference

1 reference

3

1 reference

7 November 2017

Philippe Linscheid

1

1 reference

7 November 2017

Ulrich Keller

series ordinal

2

1 reference

7 November 2017

Dominik J Schaer

series ordinal

4

1 reference

7 November 2017

Beat Müller

series ordinal

5

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

7 November 2017

published in

Biochemical Pharmacology

1 reference

7 November 2017

volume

65

1 reference

7 November 2017

issue

4

1 reference

7 November 2017

page(s)

593-598

1 reference

White adipose tissue nitric oxide synthase: a potential source for NO production

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Modulation of white adipose tissue lipolysis by nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Troglitazone inhibits the expression of inducible nitric oxide synthase in adipocytes in vitro and in vivo study in 3T3-L1 cells and Otsuka Long-Evans Tokushima Fatty rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

PPARgamma, the ultimate thrifty gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Tetrahydrobiopterin biosynthesis, regeneration and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Expression of human inducible nitric oxide synthase in a tetrahydrobiopterin (H4B)-deficient cell line: H4B promotes assembly of enzyme subunits into an active dimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Structure-function aspects in the nitric oxide synthases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Tetrahydrobiopterin synthesis is induced by LPS in vascular smooth muscle and is rate-limiting for nitric oxide production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Role of tetrahydrobiopterin availability in the regulation of nitric-oxide synthase expression in human mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Modulation of inducible nitric oxide synthase mRNA stability by tetrahydrobiopterin in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

The L-arginine-nitric oxide pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Regulation of 6-pyruvoyltetrahydropterin synthase activity and messenger RNA abundance in human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901562-9

10.1016/S0006-2952(02)01562-9

7 January 2021

Identifiers

DOI

1 reference

7 November 2017

1 reference